INAHTA Vice-Chair (2024-2026)
INEAS, Tunisia

Dr. Mouna Jameleddine is the Head of the Health Technology Assessment (HTA) department at the Tunisian Authority for Assessment and Accreditation in Healthcare (INEAS).  With more than 17 years of experience in public health, she plays a leading role in the implementation of HTA in Tunisia and the MENA region. She has contributed to several HTA capacity building activities, presented her work to a variety of scientific audiences and authored a number of scientific publications. Her main focus is on enhancing the use of HTA to make informed coverage and pricing decisions. Prior to her current role, Dr. Jameleddine collaborated within the cabinet of the Minister of Health on defining health technologies policies. Her early career as a hospital pharmacist provided her with invaluable hands-on experience in healthcare delivery in a hospital environment, inspiring her to pursue a broader role in public health and HTA.

Dr. Jameleddine has had the privilege of serving in leadership roles in various international organizations. Most notably, she was a board member and then vice-president of INAHTA (2018-2022) before re-joining as vice chair (2024-2026). She is also the co-chair of GINAHTA, a joint working group between INAHTA and the Guidelines International Network (GIN), which aims to foster collaboration between decision making disciplines. She is a member of the Advisory Board of INGUIDE (the International Guideline Training Program), which is affiliated with GIN and McMaster University. In addition, she was privileged to serve as the first chair of the HTA Roundtable for the Middle East and Africa at ISPOR from 2019 to 2023.

Dr. Jameleddine is an advisor to the WHO. She has contributed to many WHO guidelines, including the guideline on “Institutionalizing HTA mechanisms”, and has been part of several WHO expert groups, including HTA and benefit packages, cost-effectiveness data across settings, and the WHO 2021 technical advisory group (TAG) on pricing policies. She is currently a member of the WHO TAG on Medical Devices.